Back to mobile site

Goldman Sachs Upgrades Exact Sciences (EXAS) to Buy

February 26, 2019 3:34 AM EST Send to a Friend
Goldman Sachs analyst Patrick Donnelly upgraded Exact Sciences (NASDAQ: EXAS) from Neutral to Buy with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login